Decoy Therapeutics Inc.

Equities

DCOY

US79400X6022

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-08 pm EDT			5-day change	1st Jan Change
5.720 ^USD	-0.35%		-3.05%	-26.53%

May. 08	Decoy Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 09	Decoy Therapeutics Inc. - Special Call

Transcript : Decoy Therapeutics Inc. - Special Call

Published on 04/09/2026 at 05:09 pm EDT - Modified on 04/09/2026 at 10:35 pm EDT

S&P Capital IQ

Presenter Speech
Jenene Thomas (Attendees)

Okay. We are ready to get started. So good afternoon, everyone, and thank you for joining us today for our Virtual Investor Closing Bell segment. My name is

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Decoy Therapeutics Inc.

May. 08	Decoy Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 09	Decoy Therapeutics Inc. - Special Call
Apr. 02	Decoy Therapeutics regains compliance with Nasdaq minimum bid price requirement	RE
Mar. 31	Decoy Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 30	Decoy Therapeutics Inc. Auditor Raises 'Going Concern' Doubt	CI
Mar. 11	Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform	CI
Mar. 05	Decoy Therapeutics announces 1-for-12 reverse stock split	RE
Feb. 11	Decoy Therapeutics Joins Webull Corporate Connect Service Platform	CI
Jan. 23	Ladenburg Thalmann Initiates Coverage on Decoy Therapeutics With Buy Rating	MT
Jan. 13	Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform	CI
Jan. 13	Decoy Therapeutics reaches global access commitment agreement to focus on development of a globally accessible, scalable peptide-conjugate manufacturing platform	RE
Jan. 07	Salarius Pharmaceuticals, Inc. will Change its Ticker to DCOY from SLRX	CI
Jan. 07	Salarius Pharmaceuticals, Inc. will Change its Name to Decoy Therapeutics Inc	CI
Jan. 07	Salarius Pharmaceuticals changes name to Decoy Therapeutics	RE
Jan. 05	Top Midday Decliners	MT